Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KRMD
KRMD logo

KRMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy KORU Medical Systems Inc (KRMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.960
1 Day change
-0.75%
52 Week Range
6.610
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

KORU Medical Systems Inc (KRMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, and the stock is likely to decline in the short term based on historical patterns. While the company has shown revenue growth, its profitability metrics have significantly worsened. Additionally, there are no strong positive catalysts or trading signals to suggest immediate upside potential.

Technical Analysis

The technical indicators are bearish. The MACD is negative and expanding downward, RSI is neutral at 33.267, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 3.989, with resistance at 4.36.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
3

Positive Catalysts

  • Analyst B. Riley raised the price target to $8 from $7 and maintained a Buy rating, citing strong execution across strategic pillars.

Neutral/Negative Catalysts

  • No recent news or significant insider/hedge fund activity. The stock has an 80% chance of declining in the next day (-2.76%), week (-1.7%), and month (-4.24%).

Financial Performance

In 2025/Q4, revenue increased by 23.27% YoY to $10,895,328. However, net income dropped by -68.81% YoY to -$486,856, and EPS declined by -66.67% YoY to -$0.01. Gross margin slightly decreased to 60.93%, down -0.64% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

B. Riley has a Buy rating with a raised price target of $8, citing strong execution across strategic pillars.

Wall Street analysts forecast KRMD stock price to rise
5 Analyst Rating
Wall Street analysts forecast KRMD stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 3.990
sliders
Low
4
Averages
6.25
High
8
Current: 3.990
sliders
Low
4
Averages
6.25
High
8
B. Riley
B. Riley
Buy
maintain
$7 -> $8
AI Analysis
2026-03-13
Reason
B. Riley
B. Riley
Price Target
$7 -> $8
AI Analysis
2026-03-13
maintain
Buy
Reason
B. Riley raised the firm's price target on Koru Medical to $8 from $7 and keeps a Buy rating on the shares. Following the Q4 earnings report, B. Riley is "encouraged" by the continued execution across all three of its strategic pillars, the analyst tells investors in a research note.
Lake Street
Buy
upgrade
$6 -> $8
2025-12-22
Reason
Lake Street
Price Target
$6 -> $8
2025-12-22
upgrade
Buy
Reason
Lake Street raised the firm's price target on Koru Medical to $8 from $6 and keeps a Buy rating on the shares. The firm, which thinks a 510K submission for the oncology indication prior to year-end is "a meaningful catalyst, expects 2026 to be another year of growth acceleration and improving leverage, supporting revenue upside and multiple expansion, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for KRMD
Unlock Now

People Also Watch